The 17th International Winter Eicosanoid Conference
Eicosanoid Research Association, Inc.

We gratefully acknowledge the following Institutions for their support

of the 17th International Winter Eicosanoid Conference.




Image result for cayman chemical company


Corbus Pharmaceuticals Holdings, Inc. is a development stage pharmaceutical company focused on the development and commercialization of novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases. The Company’s lead product candidate, lenabasum, is a novel, synthetic oral endocannabinoid-mimetic drug designed to resolve chronic inflammation and fibrotic processes. Lenabasum is currently being evaluated in systemic sclerosis, cystic fibrosis, dermatomyositis, and systemic lupus erythematosus.



Elsevier wordmark

Prostaglandins and Other Lipid Mediators


Lipidomix - Expert in Lipid Analytics


Inception Sciences


National Institute of Environmental Health Sciences

OMEICOS Therapeutics GmbH


New York Medical College


March 11-13,2018

Baltimore, Maryland